Website growth vector outline icon
Data insight website icon

At Eradigm we work to optimize pricing and access strategy by dovetailing these with short, medium and long term product goals and strategies, contextualised within market-specific evidence requirements, payer goals, and competitive threats.

Our deep expertise in pricing, access paired with a strategy consultant approach, and evidence planning, allow us to help our clients navigate complex global P&MA environments. Our deep market-specific insights help shape and refine P&MA strategies, linking them to broader commercial goals. This mix of P&MA and broader commercial expertise allows us to serve our clients’ market access, clinical, and commercial experts.

We work across all key major and emerging markets, providing bespoke strategic support in launch price setting and adjustments, launch sequencing, competitive entry strategy, contracting strategy, and evidence generation strategies.

Market Access Strategy

  • US and Global P&MA landscape assessment
  • Global launch strategy, sequencing, and prioritisation
  • Disruptive trend analysis
  • Framework development
  • Indication sequencing
  • Portfolio P&MA strategy

Pricing and Reimbursement

  • Early pricing strategy
  • Launch pricing
  • Life cycle management pricing
  • Innovative pricing and contracting strategy
  • Contract modelling
  • Gross-to-net forecasting

Diligence support

  • P&MA due diligence
  • Assumption pressure testing

Value and evidence

  • Integrated HTA & payer evidence planning
  • Payer and value proposition development
  • Value driver analysis
  • Out of pocket pricing strategies
  • Market Access Capability Building
  • Mock negotiation workshops
  • HEOR

Our experience is built on running hundreds of Market Access projects across diverse markets and therapeutic landscapes.

The Market Access Division is headed up by Dr. Prateet Minhas.

Dr. Prateet Minhas brings to Eradigm Consulting 15+ years of experience in treating and managing the care of patients. His consulting leadership experience in supporting biopharmaceutical clients to secure market access to therapies at the optimal price across Europe and emerging markets. As Head of Market Access, Europe and Emerging Markets; Dr. Minhas’s primary focus at Eradigm Consulting is to support biotech clients to secure access at an optimal price.

Read Dr. Prateet Minhas full bio

Contact information

Fill in the contact form and a member of your team will get back to you

  • +44 (0) 203 929 0534
  • Eradigm Consulting Fora,
    180 Borough High Street,
    London, SE1 1LB
p